Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Net Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Net Sales(x) 6.198.828.92-0.030.06

What is the latest EV/Net Sales ratio of MANKIND PHARMA ?

The latest EV/Net Sales ratio of MANKIND PHARMA is 6.19 based on Mar2026 Consolidated results.
Year EV/Net Sales
Mar20266.19
Mar20258.82
Mar20248.92
Mar2023-0.03
Mar20220.06

How is EV/Net Sales of MANKIND PHARMA Trending?

Years EV/Net Sales % Change
Mar2026 6.19
-29.82
Mar2025 8.82
-1.12
Mar2024 8.92
Positive
Mar2023 -0.03
Negative
Mar2022 0.06 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Net Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹104,365.1 Cr 2.1% 7.1% -0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.1%

7.1%

-0.6%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses